Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak Securities

Indian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expected to remain stable. This outlook comes despite significant bed expansion. Hospital volumes and diagnostics are showing positive trends. The March quarter performance was robust, with sales and EBITDA growth reported. This indicates a healthy sector outlook for the coming period.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JCirLdg
via IFTTT

Read More

Regulator, cos discuss price hike for some cancer drugs

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin and cisplatin, are crucial for treating various cancers. The National Pharmaceutical Pricing Authority met with drug makers and hospital representatives to discuss the issue. Rising raw material costs have put pressure on production.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ebQqRAr
via IFTTT

Read More

Manipal Health takes Bengaluru hospital building on long-term lease

Manipal Health Enterprises has leased a 245,000-sq ft multi-speciality hospital in Bengaluru's Yelahanka for nearly 30 years, with an estimated total rental outgo of ₹816.1 crore. The lease agreement includes a starting monthly rent of ₹1.27 crore and a 10% rent escalation in the sixth year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PG2n5xB
via IFTTT

Read More

PE wars to billion-dollar IPO dreams, hospital sector is fighting fit

Major private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition highlights strong investor confidence in India's healthcare sector. The industry is entering a new growth phase driven by increasing demand, a shortage of hospital beds, and a rise in specialized medical services.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/S3xQGYv
via IFTTT

Read More

Warburg, KKR, TPG among PE giants vying for 25% stake in Cloudnine

Global private equity giants, including Warburg Pincus and KKR, are vying for a 25% stake in India's largest maternity and pediatric hospital chain, Cloudnine. The deal is expected to value the company at approximately $1 billion, with existing investor True North exiting completely. Cloudnine reported revenues of ₹2,000 crore and EBITDA of ₹300 crore in FY26.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KIsAC3d
via IFTTT

Read More

Pharma exports to US seen muted this year

Indian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are impacting shipments. US buyers are managing inventories more closely. A push for local manufacturing in the US also poses a challenge. This situation is creating caution among buyers for large forward orders.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F3B7nNP
via IFTTT

Read More

Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facility

Aurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines for global markets. US pharma giant MSD is the first major client. The plant signifies Aurobindo's expansion into the growing biologics and contract manufacturing sector. It is set to create over 1,500 jobs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EQ7zZbD
via IFTTT

Read More